Echinococcosis Hydatid Cyst Clinical Presentation

  • Author: Enrico Brunetti, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Oct 19, 2011
 

History

  • Months or years may pass before an individual exhibits any signs or symptoms of infection with the cystic larval stages.
  • During the natural course of infection, the fate of E granulosus cysts is variable.
    • Some cysts may grow to a certain size and then persist without noticeable change for many years.
    • Other cysts may rupture spontaneously or collapse and completely disappear.
  • Spontaneous or traumatic cyst rupture and spillage of viable parasitic tissue during interventional procedures may result in secondary echinococcosis. Cysts may rupture into the peritoneal or pleural cavity, the pericardium, the bile ducts, the gastrointestinal tract, or even blood vessels, leading to extraordinary manifestations and severe complications.
  • Spontaneous cure of cystic echinococcosis is possible.
  • After a variable incubation period, infections may become symptomatic if cysts are growing and exerting pressure on adjacent tissue and inducing other pathologic findings.
  • Sudden symptomatology is usually due to spontaneous or traumatic cyst rupture.
  • Usually, cysts do not induce clinical symptoms before they have reached a size sufficient to exert pressure on adjacent organs.
Next

Physical

The presentation of human echinococcosis is protean. Patients come to the clinician's attention for different reasons, such as when a large cyst has some mechanical effect on organ function or rupture of a cyst causes acute hypersensitivity reactions. The cyst may also be discovered accidentally during radiographic examination, body scanning, surgery, or for other clinical reasons.[11] Common chief symptoms are upper abdominal discomfort and pain, poor appetite, and a self-diagnosed mass in the abdomen. Physical findings are hepatomegaly, a palpable mass if on the surface of the liver or other organs, and abdominal distention. If cysts in the lung rupture into the bronchi, intense cough may develop, followed by vomiting of hydatid material and cystic membranes.[12]

  • Liver
    • Hepatomegaly
    • Jaundice
    • Biliary colic–like symptoms
    • Cholangitis
    • Pancreatitis
    • Liver abscess
    • Portal hypertension
    • Ascites
    • Inferior vena cava compression or thrombosis
    • Budd-Chiari syndrome
    • Cyst rupture, peritoneal spread, and peritonitis
    • Hemobilia
    • Biliary fistula to skin, bronchial system, or gastrointestinal tract
  • Lungs
    • Tumor of chest
    • Chest pain
    • Chronic cough, expectoration, and dyspnea
    • Pneumothorax
    • Eosinophilic pneumonitis
    • Pleural effusion
    • Parasitic lung embolism
    • Hemoptysis
    • Biliptysis
  • Heart
    • Tumor
    • Pericardial effusion
    • Embolism
  • Breast - Masses that must be differentiated from neoplasms[11]
  • Spine - Mass with neurologic symptoms
  • Brain - Mass with neurologic symptoms
Previous
Next

Causes

  • See Background for a brief discussion of infection routes.
  • Susceptibility of humans to infection varies, presumably because of individual differences in nutritional, immunologic, and genetic factors.
Previous
 
 
Contributor Information and Disclosures
Author

Enrico Brunetti, MD  Assistant Professor, Department of Infectious Diseases, Division of Infectious and Tropical Diseases, University of Pavia, Italy; Staff Physician, Department of Infectious Diseases, IRCCS S Matteo Hospital Foundation, Pavia, Italy

Enrico Brunetti, MD is a member of the following medical societies: American Society of Tropical Medicine and Hygiene and European Society of Clinical Microbiology and Infectious Diseases

Disclosure: Nothing to disclose.

Coauthor(s)

Carlo Filice, MD  Chief of Ultrasound Unit, Associate Professor, Department of Internal Medicine, IRCCS S Matteo Hospital, University of Pavia, Italy

Disclosure: Nothing to disclose.

Specialty Editor Board

Mark R Wallace, MD, FACP, FIDSA  Clinical Professor of Medicine, Florida State University College of Medicine; Head of Infectious Disease Fellowship Program, Orlando Regional Medical Center

Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

John W King, MD  Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University Health Sciences Center; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center

John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Association of Subspecialty Professors, Infectious Diseases Society of America, and Sigma Xi

Disclosure: emedicine $50.00 Author of chapter; MERCK None Other

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Larrieu E, Del Carpio M, Mercapide CH, Salvitti JC, Sustercic J, Moguilensky J, et al. Programme for ultrasound diagnoses and treatment with albendazole of cystic echinococcosis in asymptomatic carriers: 10 years of follow-up of cases. Acta Trop. Jan 2011;117(1):1-5. [Medline].

  2. Bouraoui H, Trimeche B, Mahdhaoui A, Majdoub A, Zaaraoui J, Hajri Ernez S, et al. Echinococcosis of the heart: clinical and echocardiographic features in 12 patients. Acta Cardiol. Feb 2005;60(1):39-41. [Medline].

  3. Biyik I, Acar S, Ergene O. Left atrial mobile hydatid cyst mimicking left atrial myxoma and mitral stenosis and causing heart failure and arrhythmia. Int J Cardiovasc Imaging. Apr 2007;23(2):193-5. [Medline].

  4. Tsaroucha AK, Polychronidis AC, Laftsidis PA, Pitiakoudis MS, Fotakis SN, Simopoulos CE. Primary adrenal hydatid cyst: a case report. Acta Chir Iugosl. 2007;54(2):115-7. [Medline].

  5. Tutar N, Cakir B, Geyik E, Tarhan NC, Niron EA. Hydatid cysts in breast: mammography and ultrasound findings. Br J Radiol. Oct 2006;79(946):e114-6. [Medline].

  6. Türkmen C, Unal SN, Berberoglu K, Genchellac H, Unal Z, Cantez S. Acute pulmonary embolism due to hydatid cyst. Clin Nucl Med. Nov 2004;29(11):760-1. [Medline].

  7. Yuksel BC, Ozel H, Akin T, Avsar FM, Hengirmen S. Primary hydatid cyst of the breast with elevated CA 19-9 level. Am J Trop Med Hyg. Aug 2005;73(2):368-70. [Medline].

  8. Pamir MN, Ozduman K, Elmaci I. Spinal hydatid disease. Spinal Cord. Apr 2002;40(4):153-60. [Medline].

  9. Bulman W, Coyle CM, Brentjens TE, Horn EM, Dickstein ML, Wilt JS. Severe pulmonary hypertension due to chronic echinococcal pulmonary emboli treated with targeted pulmonary vascular therapy and hepatic resection. Chest. Oct 2007;132(4):1356-8. [Medline].

  10. Bron JL, van Kemenade FJ, Verhoof OJ, Wuisman PI. Long term follow-up of a patient with disseminated spinal hydatidosis. Acta Orthop Belg. Oct 2007;73(5):678-82. [Medline].

  11. Nagpal V, Kohli K, Chowdhary A, Kumar A, Andley M, Ravi B. Breast lump as a presentation of a hydatid disease. Trop Doct. Jan 2006;36(1):57-8. [Medline].

  12. Santivanez S, Garcia HH. Pulmonary cystic echinococcosis. Curr Opin Pulm Med. May 2010;16(3):257-61. [Medline].

  13. [Guideline] Brunetti E, Kern P, Vuitton DA,. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. Apr 2010;114(1):1-16. [Medline].

  14. Macpherson CN, Bartholomot B, Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis. Parasitology. 2003;127 Suppl:S21-35. [Medline].

  15. Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiology. May 1981;139(2):459-63. [Medline].

  16. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. Feb 2003;85(2):253-61. [Medline].

  17. Junghanss T, da Silva AM, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. Sep 2008;79(3):301-11. [Medline].

  18. Brunetti E, Junghanss T. Update on cystic hydatid disease. Curr Opin Infect Dis. Oct 2009;22(5):497-502. [Medline].

  19. Hosch W, Junghanss T, Stojkovic M, Brunetti E, Heye T, Kauffmann GW. Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents. NMR Biomed. Aug 2008;21(7):734-54. [Medline].

  20. Hosch W, Stojkovic M, Jänisch T, Kauffmann GW, Junghanss T. The role of calcification for staging cystic echinococcosis (CE). Eur Radiol. Oct 2007;17(10):2538-45. [Medline].

  21. Dursun M, Terzibasioglu E, Yilmaz R, Cekrezi B, Olgar S, Nisli K, et al. Cardiac hydatid disease: CT and MRI findings. AJR Am J Roentgenol. Jan 2008;190(1):226-32. [Medline].

  22. Hosch W, Stojkovic M, Jänisch T, Heye T, Werner J, Friess H, et al. MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. Eur J Radiol. May 2008;66(2):262-7. [Medline].

  23. Neumayr A, Troia G, de Bernardis C, Tamarozzi F, Goblirsch S, Piccoli L, et al. Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review. PLoS Negl Trop Dis. Jun 2011;5(6):e1154. [Medline]. [Full Text].

  24. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone R, et al. Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis. Sep 29 2009;3(9):e524. [Medline]. [Full Text].

  25. Liu Y, Wang X, Wu J. Continuous long-term albendazole therapy in intraabdominal cystic echinococcosis. Chin Med J (Engl). Sep 2000;113(9):827-32. [Medline].

  26. Bygott JM, Chiodini PL. Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease?. Acta Trop. Aug 2009;111(2):95-101. [Medline].

  27. El Malki HO, El Mejdoubi Y, Souadka A, Mohsine R, Ifrine L, Abouqal R, et al. Predictive factors of deep abdominal complications after operation for hydatid cyst of the liver: 15 years of experience with 672 patients. J Am Coll Surg. Apr 2008;206(4):629-37. [Medline].

  28. Bagheri R, Haghi SZ, Amini M, Fattahi AS, Noorshafiee S. Pulmonary hydatid cyst: analysis of 1024 cases. Gen Thorac Cardiovasc Surg. Feb 2011;59(2):105-9. [Medline].

  29. Li Y, Zheng H, Cao X, Liu Z, Chen L. Demographic and clinical characteristics of patients with anaphylactic shock after surgery for cystic echinococcosis. Am J Trop Med Hyg. Sep 2011;85(3):452-5. [Medline]. [Full Text].

  30. Filice C, Pirola F, Brunetti E, Dughetti S, Strosselli M, Foglieni CS. A new therapeutic approach for hydatid liver cysts. Aspiration and alcohol injection under sonographic guidance. Gastroenterology. May 1990;98(5 Pt 1):1366-8. [Medline].

  31. Paksoy Y, Odev K, Sahin M, Arslan A, Koc O. Percutaneous treatment of liver hydatid cysts: comparison of direct injection of albendazole and hypertonic saline solution. AJR Am J Roentgenol. Sep 2005;185(3):727-34. [Medline].

  32. Paksoy Y, Odev K, Sahin M, Dik B, Ergül R, Arslan A. Percutaneous sonographically guided treatment of hydatid cysts in sheep: direct injection of mebendazole and albendazole. J Ultrasound Med. Aug 2003;22(8):797-803. [Medline].

  33. Smego RA Jr, Bhatti S, Khaliq AA, Beg MA. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clin Infect Dis. Oct 15 2003;37(8):1073-83. [Medline].

  34. Kabaalioglu A, Ceken K, Alimoglu E, Apaydin A. Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice?. Eur J Radiol. Jul 2006;59(1):65-73. [Medline].

  35. Khuroo MS, Wani NA, Javid G, Khan BA, Yattoo GN, Shah AH, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med. Sep 25 1997;337(13):881-7. [Medline].

  36. Men S, Yucesoy C, Edguer TR, Hekimoglu B. Percutaneous treatment of giant abdominal hydatid cysts: long-term results. Surg Endosc. Oct 2006;20(10):1600-6. [Medline].

  37. Schipper HG, Laméris JS, van Delden OM, Rauws EA, Kager PA. Percutaneous evacuation (PEVAC) of multivesicular echinococcal cysts with or without cystobiliary fistulas which contain non-drainable material: first results of a modified PAIR method. Gut. May 2002;50(5):718-23. [Medline].

  38. Ustunsoz B, Ugurel MS, Uzar AI, Duru NK. Percutaneous treatment of hepatic hydatid cyst in pregnancy: long-term results. Arch Gynecol Obstet. Oct 31 2007;[Medline].

  39. Golemanov B, Grigorov N, Mitova R, Genov J, Vuchev D, Tamarozzi F. Efficacy and safety of PAIR for cystic echinococcosis: experience on a large series of patients from Bulgaria. Am J Trop Med Hyg. Jan 2011;84(1):48-51. [Medline].

  40. Hosseini SV, Ghanbarzadeh K, Barzin J, Sadjjadi SM, Tanideh N, Mehrabani D. In vitro protoscolicidal effects of hypertonic glucose on protoscolices of hydatid cyst. Korean J Parasitol. Sep 2006;44(3):239-42. [Medline].

  41. Brunetti E, Filice C, Meroni V. Comment on percutaneous treatment of liver hydatid cysts. AJR Am J Roentgenol. Apr 2006;186(4):1198-9; author reply 1199-200. [Medline].

  42. Brunetti E, Gulizia R, Garlaschelli AL, Filice C. Cystic echinococcosis of the liver associated with repeated international travels to endemic areas. J Travel Med. Jul-Aug 2005;12(4):225-8. [Medline].

  43. Budke CM. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis. Feb 2006;12(2):296-303. [Medline].

  44. Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM. Prevention and control of cystic echinococcosis. Lancet Infect Dis. Jun 2007;7(6):385-94. [Medline].

  45. Cunha BA. Antibiotic Essentials. Royal Oak, Mich: Physicians Press; 2005.

  46. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. Jan 2004;17(1):107-35. [Medline].

  47. Franchi C, Di Vico B, Teggi A. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis. Aug 1999;29(2):304-9. [Medline].

  48. Kilic M, Yoldas O, Koc M, Keskek M, Karakose N, Ertan T, et al. Can biliary-cyst communication be predicted before surgery for hepatic hydatid disease: does size matter?. Am J Surg. Nov 2008;196(5):732-5. [Medline].

  49. Macpherson CN, Milner R. Performance characteristics and quality control of community based ultrasound surveys for cystic and alveolar echinococcosis. Acta Trop. Feb 2003;85(2):203-9. [Medline].

  50. Magistrelli P, Masetti R, Coppola R, Messia A, Nuzzo G, Picciocchi A. Surgical treatment of hydatid disease of the liver. A 20-year experience. Arch Surg. Apr 1991;126(4):518-22; discussion 523. [Medline].

  51. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet. Oct 18 2003;362(9392):1295-304. [Medline].

  52. Nasseri-Moghaddam S, Abrishami A, Taefi A, Malekzadeh R. Percutaneous needle aspiration, injection, and re-aspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts. Cochrane Database Syst Rev. 2011;(1):CD003623. [Medline].

  53. Rogan MT, Hai WY, Richardson R, Zeyhle E, Craig PS. Hydatid cysts: does every picture tell a story?. Trends Parasitol. Sep 2006;22(9):431-8. [Medline].

  54. Sayek I, Tirnaksiz MB, Dogan R. Cystic hydatid disease: current trends in diagnosis and management. Surg Today. 2004;34(12):987-96. [Medline].

Previous
Next
 
WHO Informal Working Group on Echinococcosis standardized ultrasound classification of echinococcal cysts. Image courtesy of World Health Organization (WHO).
CE1 cyst in the right segments of the liver in a young Albanian boy
CE3a echinococcal cyst of the liver. Note the folding endocyst ("waterlily sign") typical of CE3a cysts.
CE3b cyst in the right lobe of the liver. The cyst is predominantly solid with a few daughter cysts
CE4 cyst in the liver. The cyst is completely solid and inactive.
CE3b cyst in the muscles of posterior thigh (scanned with a convex ultrasound probe).
CE4 cysts in the peritoneum in a patient with disseminated echinococcosis (longitudinal scan).
Viable scolices (note rostellar hooklets).
CT scan of peritoneal, disseminated echinococcosis
MR scan of echinococcal cyst in the right psoas muscle, infiltrating the adjacent vertebral body
Ultrasound scan of a CE3b subcutaneous cyst located in the lumbar area. The cyst was the subcutaneous extension of a cyst located in the spine that had been previously operated on.
MR of the spine showing CE involvement of CE3,CE4,CE5 vertebral bodies, spinous processes and subcutaneous tissue (same patient as # )
CT scan showing CE infiltration of vertebral bodies and destruction of left peduncles
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.